Analizzare la terminologia biomedica sulle malattie rare by Pasceri, Erika
Analyzing rare diseases terms in
biomedical terminologies
Erika Pasceri
Introduction
A rare disease is a pathological condition with low prevalence
and incidence. There are between 6000 and 8000 rare diseases. Many
rare diseases are sparsely distributed in some geographic areas and
more frequent in others, for reasons linked to genetic factors, envi-
ronmental conditions that influence the spread of pathogens and the
life habits. Thalassemia, for example, is a relatively common genetic
disease in the Mediterranean basin (very common in Southern Italy)
and rare in the United States.
A disease or disorder is defined as rare in Europe when it affects
less than 5 in 10,000.1 One rare disease may affect only a handful of
patients in the EU, and another touch as many as 245,000. Overall,
rare diseases may affect 30 million European Union citizens. In
the United States a rare (or orphan) disease is defined as having
a prevalence of fewer than 200,000 affected individuals.2 Many
diseases are much rarer, reaching a rate of one case per 100,000
1http://ec.europa.eu/health-eu/health_problems/rare_diseases/index_en.
htm.
2http://www.nlm.nih.gov/medlineplus/rarediseases.html.
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persons or more.
Rare disease patients too often face common problems, including
the lack of access to correct diagnosis, delay in diagnosis, lack of
quality information on the disease, lack of scientific knowledge of
the disease, inequities and difficulties in access to treatment and
care. These things could be changed by implementing a comprehen-
sive approach to rare diseases, increasing international cooperation
in scientific research, by gaining and sharing scientific knowledge
about all rare diseases, not only the most “frequent” ones, and by
developing tools for extracting and sharing knowledge.
Organizations such as the National Institute of Health (NIH),
Office of Rare Diseases Research (ORDR), National Organization
for rare Disorders (NORD) and Orphanet provide information to
patients and physicians and facilitate the exchange of information
among different actors involved in this field by standardization
in clinical terminologies, key factors in information retrieval and
information exchange.
The ORDR was established in 1993 within the Office of the Di-
rector of the NIH, the Federal point of biomedical research. The
aim of ORDR is to coordinate and support rare disease research,
responding to research opportunities and providing information,
promoting international collaboration and interoperation.
Orphanet, on the other hand, was established in 1997 by the
French Ministry of Health (Direction Générale de la Santé)3 and the
Institut National de la Santé et de la Recherche Médicale (INSERM).4
Orphanet maintains a database of information on rare diseases and
orphan drugs for all publics and aims to contribute to the improve-
ment of the diagnosis, care and treatment of patients with rare
diseases. It includes a Professional Encyclopedia which is a compre-
3http://www.sante.gouv.fr.
4http://www.inserm.fr.
4783-2
JLIS.it. Vol. 3, n. 1 (Giugno/June 2012)
hensive collection of review articles on rare diseases, author-based
and peer-reviewed, a Patient Encyclopedia and a Directory of expert
Services. This Directory includes information on relevant clinics,
clinical laboratories, research activities and patient organizations.
The NORD was founded in 1983 by patients and families who
worked together to get the Orphan Drug Act passed. This legis-
lation provides financial incentives to encourage development of
new treatments of rare diseases. The purpose of NORD is to supply
information about rare diseases, referrals to patient organizations,
research grants and all those people that have interest in rare disease.
The purpose of NORD is to supply information about rare diseases,
referrals to patient organizations, research grants and all those peo-
ple that have interest in rare disease. It isn’t a government agency;
it is a non-profit voluntary health agency that exists to serve rare-
disease patients and their families. Its primary sources of funding
are contributions membership fees.
Objective
The aim of this project is to analyze a specific area of biomedical
terminologies, namely rare disease terms. The representation of rare
diseases terms has been analyzed in biomedical terminologies such
as Medical Subject Headings (MeSH), International Classification
of Diseases (ICD)-10, Systematized Nomenclature of Medicine -
Clinical Terms (SNOMED-CT) and Online Mendelian Inheritance
in Man (OMIM), leveraging the fact that these terminologies are
integrated in the Unified Medical Language System (UMLS). It has
been analyzed the overlap among sources and the presence of rare
diseases terms in target sources included in UMLS, working at the
term and concept level.
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Material
In this section the resources used in this study are briefly de-
scribed: the two sources of rare disease terms (ORDR and Or-
phanet), the four target terminologies (ICD, MeSH, OMIM, and
SNOMED-CT) and the UMLS.
The UMLS R©is a terminology integration system developed at
the National Library of Medicine. The UMLS Metathesaurus R© in-
tegrates almost 160 biomedical vocabularies, including the four
target vocabularies under investigation (ICD-10, MeSH, OMIM and
SNOMED-CT). Synonymous terms from the various source vocabu-
laries are grouped into one concept. Additionally, the Metathesaurus
records the relations asserted among terms in the source vocabu-
laries, including hierarchical, associative and mapping relations.
Version 2010AB of the UMLS is used in this study. This version
contains approximately 2.4 M concepts and 40 M relations.
Source terminologies
The ORDR5 publishes a list of rare diseases. This resource does
not represent any relations among rare diseases, but groups all the
synonyms of a given disorder into a single concept. It maintains a
list of 6,857 rare disease concepts (and 11,803 synonyms) on its Web
site of which about 800 have extensive information on resources
relating to questions by the public. The rare disease concepts are
either diseases for which information requests have been made to
directly to the Office of Rare Diseases Research, the Genetic and Rare
Diseases Information Center (GARD) which is funded by theORDR
and the National Human Genome Research Institute (NHGRI), or
NHGRI directly; or (2) diseases from various data sources and those
5http://rarediseases.info.nih.gov.
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that over the last 10 years have been suggested as being rare. The
purpose of the Rare Diseases and Related Terms list is to facilitate
the distribution of information.
Orphanet6 provides information about 5,954 rare diseases. Orphanet
diseases are organized into a Directed Acyclic Graph. In the Or-
phanet database, diseases are linked to external reference terminolo-
gies, such as ICD10 and OMIM. The Orphanet list of rare diseases
comprises 7,715 concepts. We acquired a list of 7,715 preferred terms
and 5,224 synonyms. Additionally, Orphanet shared with us the
correspondence they established between rare disease concepts and
OMIM and ICD10 codes.
Target terminologies
The ICD is the international standard diagnostic classification for
all general epidemiological, many health management purposes and
clinical use. It is used to classify diseases and other health problems
recorded on many types of health and vital records including death
certificates and health records. In addition to enabling the storage
and retrieval of diagnostic information for clinical, epidemiological
and quality purposes, these records also provide the basis for the
compilation of national mortality and morbidity statistics by World
Health Organization World Health Organization (WHO) Member
States. The 10th revision of ICD (ICD-10) is used in this study. It is
included in UMLS.
The MeSH is a controlled vocabulary developed by the U.S. Na-
tional Library of Medicine for the indexing and retrieval of the
biomedical literature, especially in the MEDLINE bibliographic
database. It consists of sets of terms naming some 25,000 descriptors
6http://www.orpha.net.
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in a hierarchical structure that permits searching at various levels of
specificity. Version 2011 of MeSH is used in this study. Of note, this
version provides partial coverage for the rare disease terms from
ORDR. MeSH is one of the terminologies in the UMLS.
The OMIM is a comprehensive, authoritative, and timely com-
pendium of human genes and genetic phenotypes developed at John
Hopkins University. The full-text, referenced overviews in OMIM
contain information on all known Mendelian disorders and over
12,000 genes. OMIM focuses on the relationship between phenotype
and genotype. Its terminological component – including clinical
synopses – is available through the UMLS.
The Systematized Nomenclature of Medicine (SNOMED-CT)
is the world’s largest clinical terminology developed by the In-
ternational Health Terminology Standard Development Organiza-
tion (IHTSDO) for use in electronic health records. It covers most
areas of clinical information such as diseases, findings, procedures,
microorganisms, pharmaceuticals etc. SNOMED-CT provides a con-
sistent way to index, store, retrieve, and aggregate clinical data
across specialties and sites of care. It also helps organizing the con-
tent of medical records, reducing the variability in the way data is
captured, encoded and used for clinical care of patients and research.
The version of SNOMED-CT used in this study is dated July 31, 2010
and is integrated in the UMLS.
In the remainder of this paper, for simplification purpose, ORDR
and Orphanet will be named as sources and SNOMED-CT, MeSH,
OMIM and ICD10 as the targets.
Method
UMLS has been used in various data creation, indexing and
encoding systems. It accomplishes this by conjoining the sets of
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synonyms and concept relationships in its multiple constituent ter-
minologies (Merabti et al.). In this study rare disease terms from the
two sources were mapped to the corresponding UMLS concept(s) us-
ing an exact match or after normalization. Normalization abstracts
away from such unessential differences as case, punctuation, and
inflectional variants (e.g., singular vs. plural) and stop words in
terms:
Ex. Glycogen storage disease type 4→ C0017923 (Exact Match);
Ex. Isolated growth hormone deficiency type IA→ C1849790 (Normal-
ized String).
Because the terms from ORDR and Orphanet are all expected
to name (rare) disorders, we restricted the UMLS concepts mapped
to disorder concepts through a filter based on the Semantic Group
Disorders (including such semantic types asDisease or Syndrome and
Congenital Abnormality). This simple filter provides some level of
word sense disambiguation.
Results
The first results of the mapping from the sources to UMLS could
be summarized in three categories:
1. Unambiguous concepts
All the terms of a given concept map to only one Concept
Unique Identifiers (CUI):
Ex. ORD00117 (Acrodysostosis)→ C0220659 (Acrodysostosis);
Ex. ORPHA001248 (Maxillo-nasal dysplasia)→C0220692 (MAXILLONASAL
DYSPLASIA, BINDER TYPE);
Ex. NORD00312 (Conn Syndrome)→ C1384514 (Conn Syndrome).
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2. Ambiguous concepts
The majority of terms of a given concept map to more than
one CUIs. There are two more sub-categories:
• Ambiguous concepts related to granularity issue:
ORPHA0000 CUI 1 (C0268128) CUI 2 (C0220987) CUI 3 (C0268131)
Oroticaciduria Orotic aciduria
Orotic aciduria hereditary Hereditary orotic aciduria
Orotidylic decarboxylase
deficiency Hereditary orotic aciduria, type 2
Uridine monophosphate
synthetase deficiency — — —
Table 1: Example of an ambiguous concept related to granularity issue
As shown in table 1, from a given Orphanet concept, three
terms match to three different CUIs and one match to noth-
ing. In this specific case Orphanet grouped together what
SNOMED-CT put in hierarchy:
• Ambiguous concept not related to granularity issue:
Figure 1
As shown in table 2 on the facing page, from a given Orphanet
concept, the terms match to several CUIs, but from UMLS
4783-8
JLIS.it. Vol. 3, n. 1 (Giugno/June 2012)
ORPHA000016 CUI1 (C0339537) CUI2 (C1844778))
Blue cone monochromatism Blue cone monochromatism
Achromatopsia incomplete, X-linked Achromatopsia, incomplete, x-linked
Achromatopsia, atypical, X linked — —
S-cone monochromatism — —
Table 2: Example of an ambiguous concept not related to granularity issue.
perspective we don’t have any additional information because
both terms come from OMIM, so we don’t have any informa-
tion about hierarchical relations.
3. Unmatched Concepts
There are some terms from the sources that have no mapping
in target sources in UMLS:
• Lateral body wall complex
• Levy-Yeboa Syndrome
The possible explanation for that could be because these are
extremely rare diseases (e.g. Lateral body wall complex, ap-
proximately 250 cases have been reported in the literature so
far) or recently discovered (e.g. Levy-Yeboa Syndrome, discov-
ered in June 2006).
Overall representation in targets
The figure 2 on page 11 shows a part of the overall representation
in target sources in the UMLS. On the total number of concepts
mapped to UMLS (8,435), we noticed a good representation in the
sources we focused the attention:
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1. MeSH 5,663 (67%)
2. SNOMED-CT 4,192 (50%)
3. OMIM 3,802 (45%)
4. ICD10 1,029 (12%)
As shown in figure 2 on the facing page, the blank columns
represent those sources that have a very small number of mappings
(only one or two). This is because some of them were created for a
specific context, e.g.:
• NANDA nursing diagnoses: definitions & classification (NAN)
• Ultrasound Structured Attribute Reporting (ULT)
• Foundational Model of Anatomy Ontology (FMA)
Overlap among sources
Figure 3 on page 127 shows the representation of the overlap
among sources. From the ORDR perspective there is 59% of com-
mon concepts with Orphanet and 13% with NORD; from Orphanet
perspective there is the 43% of common concepts with ORDR and
17% with NORD; and from NORD perspective, there is the 97% of
common concepts with ORDR and 92% with Orphanet.
Additional information for a given concept
from sources
Among the objectives of this work we set out to find, where pro-
vided, additional information for the given concepts from rare dis-
7For better details, see http://leo.cilea.it/index.php/jlis/article/
downloadSuppFile/4783/5747.
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Figure 2: Overlap among sources and representation in targets
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Figure 3: Overlap among sources
eases lists. After analyzing the representation in the target sources,
we went deeper in details to find synonyms and more specific terms
from target vocabularies. As shown in the example below, from
a given concept common in the starting sources, we found that
SNOMED-CT can provide additional synonyms and descendants:
Cryptococcosis:
• Torulosis
• Busse-Buschke’s disease
• European blastomycosis
• European Blastomycosis
• Busse-Buschke disease
Additional synonyms provided by SNOMED-CT:
• European cryptococcosis
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• Infection by Cryptococcus neoformans
• Torula
Additional descendants provided by SNOMED-CT:
• Systemic cryptococcosis
• Cryptococcal gastroenteritis
• Cryptococcosis associated with AIDS
• Cryptococcus infection of the central nervous system
• Disseminated cryptococcosis
• Hepatic cryptococcosis
• Mucocutaneous cryptococcosis
• Ocular cryptococcosis
• Osseous cryptococcosis
• Pulmonary cryptococcosis
Limitations
In some cases we didn’t find any correspondence of terms or
concepts in UMLS. This is partly because everything is seen from
UMLS perspective; which is because the target sources organize
in different ways the terms from their perspectives that makes the
difference among the several vocabularies included in UMLS. We
also noticed that some concepts not present in UMLS, but probably
because there are some diseases that are extremely rare and also
because some of them have been recently discovered. If we focus the
attention only on Orphanet, maybe we overestimated the percentage
of unmapped concepts because in the list of terms there are some
that are very general terms as “rare genetic skin disease” versus what
we have in target sources really specific as “xeroderma pigmentosus”.
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Conclusion
Rare diseases are insufficiently and inconsistently represented in
medical terminologies. More than 50% of rare diseases concepts are
still not aligned. Automatic approaches can be used to create a draft
of the alignment and facilitate the work of domain experts. We found
a good representation in target sources in UMLS, especially in the
sources where we focused the attention; we also found additional
information for the rare diseases concepts. We will share the result
with the organizations that work in this particular field so that to
enhance the information retrieval. They will provide to review all
data with the supervision of clinical experts. This work could be
also a feedback to UMLS, for those terms that ORDR, Orphanet and
NORD grouped together and UMLS doesn’t.
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ABSTRACT: Rare disease patients too often face common problems, including the
lack of access to correct diagnosis, lack of quality information on the disease, lack of
scientific knowledge of the disease, inequities and difficulties in access to treatment
and care. These things could be changed by implementing a comprehensive approach
to rare diseases, increasing international cooperation in scientific research, by gaining
and sharing scientific knowledge about and by developing tools for extracting and
sharing knowledge. A significant aspect to analyze is the organization of knowledge
in the biomedical field for the proper management and recovery of health informa-
tion. For these purposes, the sources needed have been acquired from the Office of
Rare Diseases Research, the National Organization of Rare Disorders and Orphanet,
organizations that provide information to patients and physicians and facilitate the
exchange of information among different actors involved in this field. The present
paper shows the representation of rare diseases terms in biomedical terminologies
such as MeSH, ICD-10, SNOMED CT and OMIM, leveraging the fact that these termi-
nologies are integrated in the UMLS. At the first level, it was analyzed the overlap
among sources and at a second level, the presence of rare diseases terms in target
sources included in UMLS, working at the term and concept level. We found that
MeSH has the best representation of rare diseases terms.
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